Announcements Trials
Browse Landscape

Phase

Phase 2 59Phase 3 24Phase 2/3 6Phase NA 4Phase 1/2 4Phase 1 3Phase 4 2

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 2Esophageal Neoplasms 1

Interventions

Cyclophosphamide 624pembrolizumab 500Paclitaxel 456Gemcitabine 438Carboplatin 435Cisplatin 418Radiotherapy 380fludarabine 365Nivolumab 340Docetaxel 277Bevacizumab 276Irinotecan 257Magnetic Resonance Spectroscopy 242Fluorouracil 228Dexamethasone 225Specimen Handling 221Capecitabine 218Rituximab 205Cytarabine 201Oxaliplatin 200Ipilimumab 199Temozolomide 197Biopsy 196fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 173Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Interventional × XELOX × Clear all
NCT07453875 2026-04-27

TRIUNITE06

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 1 Not yet recruiting
9 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06848465 2026-04-03

LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase 1 Recruiting
9 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT01490749 2019-03-15

Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer

Emory University

Phase 1 Completed
17 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡